Partnership of BC Platforms, Euformatics, and Oncompass Medicine, Selected to Deliver Standardized Oncology NGS Workflows for Seven Major European Hospitals

Read full release

TILT Biotherapeutics Announces Boston Office Opening as it Expands its Clinical Trials in the US Helsinki, Finland

Read full release

SiSaf’s Innovative RNA Therapeutic for Rare Genetic Skeletal Disorders Begins the U.S. Regulatory Process for Orphan Drug Designation

Read full release